Stericycle (NASDAQ:SRCL) had its price target boosted by Royal Bank of Canada to $75.00 in a research report sent to investors on Friday, The Fly reports. They currently have an underperform rating on the business services provider’s stock.

Other equities research analysts also recently issued reports about the company. BidaskClub downgraded Stericycle from a hold rating to a sell rating in a research report on Thursday, January 11th. Zacks Investment Research upgraded Stericycle from a sell rating to a hold rating in a research report on Wednesday, January 10th. Oppenheimer reiterated a hold rating on shares of Stericycle in a research report on Wednesday, December 13th. BMO Capital Markets decreased their price objective on Stericycle from $74.00 to $62.00 and set a market perform rating on the stock in a research report on Friday, November 10th. Finally, Jefferies Group set a $108.00 price objective on Stericycle and gave the company a buy rating in a research report on Tuesday, October 17th. Three equities research analysts have rated the stock with a sell rating, five have assigned a hold rating and six have given a buy rating to the company. The stock currently has an average rating of Hold and a consensus price target of $75.18.

Stericycle (SRCL) traded up $0.47 during trading hours on Friday, hitting $72.00. The company had a trading volume of 806,300 shares, compared to its average volume of 677,254. The company has a quick ratio of 0.82, a current ratio of 0.82 and a debt-to-equity ratio of 0.93. The stock has a market capitalization of $6,146.85, a P/E ratio of -126.31, a P/E/G ratio of 1.75 and a beta of 0.16. Stericycle has a 12 month low of $61.25 and a 12 month high of $88.00.

Stericycle (NASDAQ:SRCL) last posted its earnings results on Wednesday, November 8th. The business services provider reported $1.10 EPS for the quarter, missing analysts’ consensus estimates of $1.14 by ($0.04). The firm had revenue of $883.00 million during the quarter, compared to analysts’ expectations of $896.81 million. Stericycle had a positive return on equity of 13.93% and a negative net margin of 0.79%. Stericycle’s quarterly revenue was down .8% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.24 earnings per share. equities research analysts predict that Stericycle will post 4.49 earnings per share for the current year.

In other Stericycle news, Director Mark C. Miller sold 19,753 shares of the company’s stock in a transaction that occurred on Monday, November 13th. The stock was sold at an average price of $64.03, for a total transaction of $1,264,784.59. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Over the last 90 days, insiders have sold 79,012 shares of company stock worth $5,240,668. Company insiders own 3.50% of the company’s stock.

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Smith Graham & Co. Investment Advisors LP grew its stake in shares of Stericycle by 33.1% during the fourth quarter. Smith Graham & Co. Investment Advisors LP now owns 92,890 shares of the business services provider’s stock valued at $6,316,000 after buying an additional 23,110 shares during the last quarter. Addison Capital Co bought a new position in shares of Stericycle during the fourth quarter valued at approximately $826,000. State of Alaska Department of Revenue grew its stake in shares of Stericycle by 71.6% during the fourth quarter. State of Alaska Department of Revenue now owns 14,690 shares of the business services provider’s stock valued at $998,000 after buying an additional 6,130 shares during the last quarter. Mondrian Investment Partners LTD bought a new position in shares of Stericycle during the fourth quarter valued at approximately $48,672,000. Finally, Community Financial Services Group LLC grew its stake in shares of Stericycle by 1.5% during the fourth quarter. Community Financial Services Group LLC now owns 53,975 shares of the business services provider’s stock valued at $3,669,000 after buying an additional 795 shares during the last quarter. 94.32% of the stock is currently owned by hedge funds and other institutional investors.

TRADEMARK VIOLATION NOTICE: “Stericycle (SRCL) Price Target Raised to $75.00 at Royal Bank of Canada” was originally reported by Daily Political and is the property of of Daily Political. If you are reading this piece of content on another site, it was stolen and republished in violation of US & international trademark and copyright law. The original version of this piece of content can be viewed at https://www.dailypolitical.com/2018/01/22/stericycle-srcl-price-target-raised-to-75-00-at-royal-bank-of-canada.html.

Stericycle Company Profile

Stericycle, Inc is a business-to-business services provider. The Company focuses on regulated and compliance solutions for healthcare, retail, and commercial businesses. The Company’s segments include Domestic and Canada Regulated Waste and Compliance Services (RCS), Domestic Communication and Related Services (CRS), International RCS and All other.

The Fly

Analyst Recommendations for Stericycle (NASDAQ:SRCL)

Receive News & Ratings for Stericycle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle and related companies with MarketBeat.com's FREE daily email newsletter.